<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on July 28, 2020</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT03894423</url>
  </required_header>
  <id_info>
    <org_study_id>IRB-49945</org_study_id>
    <secondary_id>1R01HL141712-01A1</secondary_id>
    <secondary_id>MZ-0048352</secondary_id>
    <nct_id>NCT03894423</nct_id>
  </id_info>
  <brief_title>Comprehensive Computed Tomography Guidance of Coronary Bypass Graft Surgery</brief_title>
  <official_title>Comprehensive CT Guided Coronary Bypass Graft Surgery</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Stanford University</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
    <collaborator>
      <agency>National Heart, Lung, and Blood Institute (NHLBI)</agency>
      <agency_class>NIH</agency_class>
    </collaborator>
    <collaborator>
      <agency>University of California, San Diego</agency>
      <agency_class>Other</agency_class>
    </collaborator>
    <collaborator>
      <agency>VA Palo Alto Health Care System</agency>
      <agency_class>U.S. Fed</agency_class>
    </collaborator>
  </sponsors>
  <source>Stanford University</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
  </oversight_info>
  <brief_summary>
    <textblock>
      Apply CT angiography, CT perfusion imaging and advanced image processing techniques to
      improve revascularization decision-making and surgical strategies in patients undergoing
      coronary artery bypass graft surgery.
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      The objective of this study is to integrate noninvasively acquired anatomical and functional
      information to develop clinically applicable tools for meaningful per-vessel
      revascularization decisions. The decisions will be based on quantitative lesion-specific
      ischemia and viability and flow simulations. These will be based on CT anatomy enhanced with
      a function for prediction of hemodynamic improvement after CABG.

      Aim 1: Predict restoration of myocardial perfusion from coronary artery bypass graft surgery.
      The investigators will perform cardiac CT before and after CABG and measure absolute changes
      in myocardial perfusion as the functional outcome of CABG. The investigators will investigate
      clinical, surgical and imaging variables in association with post-CABG perfusion improvement
      on a per-vessel and per-patient level.

      Aim 2: Non-invasively quantify vessel-specific ischemia for meaningful CABG decisions.

      The investigators will develop and validate tools for assessment of vessel-specific ischemia
      and viability. The investigators will assess the potential impact of CT guided CABG by
      comparing the per-vessel need for grafting with standard care.

      Aim 3: Predict CABG benefit through multi-parameter flow simulations Hypothesis: Integration
      of myocardial perfusion and viability can improve flow simulation models to predict CABG
      outcome. The investigators will develop new computational fluid dynamics models enriched with
      functional parameters and explore the potential of virtual grafting to improve hemodynamic
      outcomes.
    </textblock>
  </detailed_description>
  <overall_status>Recruiting</overall_status>
  <start_date type="Actual">May 1, 2019</start_date>
  <completion_date type="Anticipated">July 2023</completion_date>
  <primary_completion_date type="Anticipated">July 2022</primary_completion_date>
  <study_type>Observational</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <observational_model>Case-Only</observational_model>
    <time_perspective>Prospective</time_perspective>
  </study_design_info>
  <primary_outcome>
    <measure>Change in myocardial blood flow from baseline measured by cardiac CT</measure>
    <time_frame>2 Months</time_frame>
    <description>Myocardial blood flow will be measured by dynamic stress CT perfusion imaging before and 2 months after CABG. The primary endpoint is the difference MBF values between both examinations, per coronary distribution.</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>Bypass graft obstruction by cardiac CT</measure>
    <time_frame>2 Months</time_frame>
    <description>The presence of bypass grafts obstruction will be assessed on CT angiography</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Change in angina pectoris assessed by SAQ</measure>
    <time_frame>1 Year</time_frame>
    <description>Severity of anginal complaints will be assessed using the Seattle Angina Questionnaire before and 1 year after CABG.</description>
  </secondary_outcome>
  <enrollment type="Anticipated">200</enrollment>
  <condition>CAD</condition>
  <condition>Atheroscleroses, Coronary</condition>
  <condition>Computed Tomography</condition>
  <condition>Coronary Artery Bypass</condition>
  <eligibility>
    <study_pop>
      <textblock>
        Patients scheduled to undergo coronary bypass graft surgery
      </textblock>
    </study_pop>
    <sampling_method>Non-Probability Sample</sampling_method>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  Planned elective CABG for coronary artery disease.

          -  CABG is the primary indication for surgery (but may include treatment of mild-moderate
             valvular disease).

          -  Age: â‰¥40 years.

        Exclusion Criteria:

          -  Technical feasibility of the cardiac CT exams: redo-CABG, significant
             arrhythmia/mal-conduction, congenital conditions, severe valvular disease or
             cardiomyopathy (to the extent that the CT acquisition is technically challenged),
             inadequate understanding of the English language (to provide consent or follow
             instructions during the exams).

          -  Overall safety: unstable clinical condition (clinical heart failure, unstable angina,
             myocardial infarction &lt;1 month prior).

          -  Radiation risk: pregnancy (cannot be ruled out), body weight &gt;100kg.

          -  CT contrast medium-related: known allergy, renal failure

          -  Vasodilator related: known allergy, bronchial asthma requiring daily use of
             bronchodilators, Mobitz II or 3rd degree AV block, sick sinus node disease, clinically
             significant carotid artery narrowing, severe aortic stenosis or LVOT narrowing,
             systolic blood pressure below 90mmHg, (continued) use of dipyridamole or
             aminophylline.

          -  Inability to provide informed consent.
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>40 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Koen Nieman, MD, PhD</last_name>
    <role>Principal Investigator</role>
    <affiliation>Stanford University</affiliation>
  </overall_official>
  <overall_contact>
    <last_name>Gerri O'Riordian, RN</last_name>
    <phone>(650) 725-5597</phone>
    <email>gor@stanford.edu</email>
  </overall_contact>
  <location>
    <facility>
      <name>Palo Alto Veterans Affaird Healthcare System</name>
      <address>
        <city>Palo Alto</city>
        <state>California</state>
        <zip>94304</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Grace Liang</last_name>
    </contact>
    <investigator>
      <last_name>Patricia Nguyen, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Stanford University</name>
      <address>
        <city>Palo Alto</city>
        <state>California</state>
        <zip>94304</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Sujana Balla, MBBS</last_name>
      <phone>650-736-4363</phone>
      <email>sujanaballa@stanford.edu</email>
    </contact>
    <investigator>
      <last_name>Koen Nieman, MD, PhD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>University of California San Diego</name>
      <address>
        <city>San Diego</city>
        <state>California</state>
        <zip>92093</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Not yet recruiting</status>
    <investigator>
      <last_name>Andrew Kahn, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location_countries>
    <country>United States</country>
  </location_countries>
  <verification_date>September 2019</verification_date>
  <study_first_submitted>March 22, 2019</study_first_submitted>
  <study_first_submitted_qc>March 27, 2019</study_first_submitted_qc>
  <study_first_posted type="Actual">March 28, 2019</study_first_posted>
  <last_update_submitted>September 18, 2019</last_update_submitted>
  <last_update_submitted_qc>September 18, 2019</last_update_submitted_qc>
  <last_update_posted type="Actual">September 19, 2019</last_update_posted>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>Stanford University</investigator_affiliation>
    <investigator_full_name>Koen Nieman</investigator_full_name>
    <investigator_title>Associate Professor</investigator_title>
  </responsible_party>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Atherosclerosis</mesh_term>
    <mesh_term>Coronary Artery Disease</mesh_term>
    <mesh_term>Myocardial Ischemia</mesh_term>
  </condition_browse>
  <patient_data>
    <sharing_ipd>No</sharing_ipd>
    <ipd_description>No current plan to share data</ipd_description>
  </patient_data>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

